EP300 mutations have been found in many cancers including CRC; however, its precise role in tumorigenesis is debated and contradictory, since some studies showed a tumor suppressor function, while others showed oncogenic co-activation properties [30,31]. The gene discussed is EP300; the disease is colorectal carcinoma.